- Home
- JQC vs TRNS Comparison
JQC vs TRNS Comparison
Compare JQC & TRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JQC | TRNS |
|---|---|---|
| Founded | 2003 | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Electrical Products |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 681.4M | 807.1M |
| IPO Year | 2003 | 1995 |
Fundamental Metrics
Financial Performance| Metric | JQC | TRNS |
|---|---|---|
| Price | $4.57 | $105.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $110.80 |
| AVG Volume (30 Days) | ★ 601.8K | 165.8K |
| Earning Date | 01-01-0001 | 11-03-2026 |
| Dividend Yield | ★ 11.13% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.40 |
| Revenue | N/A | ★ $331,877,000.00 |
| Revenue This Year | N/A | $21.36 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $263.70 |
| Revenue Growth | N/A | ★ 19.20 |
| 52 Week Low | $4.45 | $50.23 |
| 52 Week High | $5.18 | $112.44 |
Technical Indicators
Market Signals| Indicator | JQC | TRNS |
|---|---|---|
| Relative Strength Index (RSI) | 48.15 | 63.29 |
| Support Level | N/A | $79.34 |
| Resistance Level | $4.86 | N/A |
| Average True Range (ATR) | 0.06 | 4.18 |
| MACD | 0.01 | 1.81 |
| Stochastic Oscillator | 38.48 | 73.87 |
Price Performance
Historical ComparisonAbout JQC Nuveen Credit Strategies Income Fund Shares of Beneficial Interest
Nuveen Credit Strategies Income Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. The Fund mainly invests in senior loans, high-yield corporate debt, and collateralized loan obligation (CLO) debt.
About TRNS Transcat Inc.
Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.